With CDI becoming more common, FMT is gaining increasing prominence, with some experts calling for it to become the first-line therapy for CDI.[8] FMT has been used experimentally to treat other gastrointestinal diseases including colitis, constipation, irritable bowel syndrome, as well as neurological conditions such as multiple sclerosis and Parkinson's.[9][10] In the United States, human feces has been regulated as an experimental drug since 2013. In the United Kingdom, FMT regulation is under the remit of the Medicines and Healthcare products Regulatory Agency.[11]